Annual Gross Profit
$66.07 M
+$5.25 M+8.64%
31 December 2023
Summary:
Harvard Bioscience annual gross profit is currently $66.07 million, with the most recent change of +$5.25 million (+8.64%) on 31 December 2023. During the last 3 years, it has risen by +$8.03 million (+13.84%). HBIO annual gross profit is now -2.34% below its all-time high of $67.65 million, reached on 31 December 2021.HBIO Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$12.77 M
-$453.00 K-3.43%
30 September 2024
Summary:
Harvard Bioscience quarterly gross profit is currently $12.77 million, with the most recent change of -$453.00 thousand (-3.43%) on 30 September 2024. Over the past year, it has dropped by -$1.96 million (-13.32%). HBIO quarterly gross profit is now -34.74% below its all-time high of $19.56 million, reached on 31 December 2021.HBIO Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$57.08 M
-$1.96 M-3.32%
30 September 2024
Summary:
Harvard Bioscience TTM gross profit is currently $57.08 million, with the most recent change of -$1.96 million (-3.32%) on 30 September 2024. Over the past year, it has dropped by -$8.50 million (-12.96%). HBIO TTM gross profit is now -16.89% below its all-time high of $68.68 million, reached on 30 June 2022.HBIO TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HBIO Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.6% | -13.3% | -13.0% |
| 3 y3 years | +13.8% | -21.7% | -13.3% |
| 5 y5 years | +4.6% | -14.8% | -13.3% |
HBIO Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2.3% | +13.8% | -34.7% | +4.9% | -16.9% | at low |
| 5 y | 5 years | -2.3% | +13.8% | -34.7% | +4.9% | -16.9% | at low |
| alltime | all time | -2.3% | +871.2% | -34.7% | +199.0% | -16.9% | +1237.1% |
Harvard Bioscience Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.77 M(-3.4%) | $57.08 M(-3.3%) |
| June 2024 | - | $13.22 M(-10.5%) | $59.04 M(-5.5%) |
| Mar 2024 | - | $14.77 M(-9.5%) | $62.50 M(-5.4%) |
| Dec 2023 | $66.07 M(+8.6%) | $16.32 M(+10.9%) | $66.07 M(+0.8%) |
| Sept 2023 | - | $14.73 M(-11.7%) | $65.58 M(+4.1%) |
| June 2023 | - | $16.67 M(-9.1%) | $63.02 M(+0.1%) |
| Mar 2023 | - | $18.35 M(+15.9%) | $62.99 M(+3.6%) |
| Dec 2022 | $60.82 M(-10.1%) | $15.83 M(+30.1%) | $60.82 M(-5.8%) |
| Sept 2022 | - | $12.17 M(-26.8%) | $64.55 M(-6.0%) |
| June 2022 | - | $16.64 M(+2.8%) | $68.68 M(+0.4%) |
| Mar 2022 | - | $16.18 M(-17.3%) | $68.40 M(+1.1%) |
| Dec 2021 | $67.65 M(+16.6%) | $19.56 M(+19.9%) | $67.65 M(+2.8%) |
| Sept 2021 | - | $16.31 M(-0.3%) | $65.80 M(+4.5%) |
| June 2021 | - | $16.35 M(+6.0%) | $62.99 M(+4.1%) |
| Mar 2021 | - | $15.43 M(-12.9%) | $60.49 M(+4.2%) |
| Dec 2020 | $58.04 M(-9.8%) | $17.71 M(+31.2%) | $58.04 M(+0.8%) |
| Sept 2020 | - | $13.49 M(-2.6%) | $57.57 M(-2.5%) |
| June 2020 | - | $13.86 M(+6.7%) | $59.05 M(-3.4%) |
| Mar 2020 | - | $12.98 M(-24.7%) | $61.15 M(-4.9%) |
| Dec 2019 | $64.32 M(+1.8%) | $17.23 M(+15.1%) | $64.32 M(-2.3%) |
| Sept 2019 | - | $14.98 M(-6.1%) | $65.83 M(-1.3%) |
| June 2019 | - | $15.96 M(-1.2%) | $66.67 M(+0.9%) |
| Mar 2019 | - | $16.15 M(-13.8%) | $66.07 M(+4.6%) |
| Dec 2018 | $63.18 M(+61.3%) | $18.74 M(+18.5%) | $63.18 M(+13.9%) |
| Sept 2018 | - | $15.82 M(+3.0%) | $55.46 M(+12.9%) |
| June 2018 | - | $15.36 M(+15.7%) | $49.14 M(+14.7%) |
| Mar 2018 | - | $13.27 M(+20.4%) | $42.86 M(+9.4%) |
| Dec 2017 | $39.17 M(-19.1%) | $11.02 M(+16.0%) | $39.17 M(-2.7%) |
| Sept 2017 | - | $9.50 M(+4.7%) | $40.26 M(-5.2%) |
| June 2017 | - | $9.07 M(-5.3%) | $42.45 M(-5.8%) |
| Mar 2017 | - | $9.58 M(-20.9%) | $45.05 M(-7.0%) |
| Dec 2016 | $48.41 M(-0.6%) | $12.11 M(+3.6%) | $48.41 M(-1.7%) |
| Sept 2016 | - | $11.69 M(+0.1%) | $49.23 M(-0.1%) |
| June 2016 | - | $11.68 M(-9.8%) | $49.27 M(-1.8%) |
| Mar 2016 | - | $12.95 M(+0.2%) | $50.19 M(+3.0%) |
| Dec 2015 | $48.72 M(-1.3%) | $12.92 M(+10.2%) | $48.72 M(-1.9%) |
| Sept 2015 | - | $11.73 M(-6.9%) | $49.66 M(+0.6%) |
| June 2015 | - | $12.60 M(+9.7%) | $49.38 M(+0.6%) |
| Mar 2015 | - | $11.48 M(-17.2%) | $49.06 M(-0.6%) |
| Dec 2014 | $49.34 M(+3.5%) | $13.86 M(+21.2%) | $49.34 M(+3.8%) |
| Sept 2014 | - | $11.44 M(-6.8%) | $47.53 M(+0.3%) |
| June 2014 | - | $12.28 M(+4.4%) | $47.39 M(+0.4%) |
| Mar 2014 | - | $11.76 M(-2.4%) | $47.20 M(-1.0%) |
| Dec 2013 | $47.70 M(-8.9%) | $12.05 M(+6.6%) | $47.70 M(-2.6%) |
| Sept 2013 | - | $11.30 M(-6.5%) | $48.98 M(-1.4%) |
| June 2013 | - | $12.09 M(-1.4%) | $49.67 M(-3.0%) |
| Mar 2013 | - | $12.26 M(-8.0%) | $51.20 M(-2.2%) |
| Dec 2012 | $52.34 M | $13.33 M(+11.1%) | $52.34 M(+0.3%) |
| Sept 2012 | - | $11.99 M(-11.9%) | $52.17 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $13.62 M(+1.6%) | $52.05 M(+1.6%) |
| Mar 2012 | - | $13.40 M(+1.8%) | $51.22 M(+2.1%) |
| Dec 2011 | $50.19 M(-3.1%) | $13.16 M(+10.8%) | $50.19 M(-2.4%) |
| Sept 2011 | - | $11.88 M(-7.1%) | $51.44 M(-1.3%) |
| June 2011 | - | $12.79 M(+3.4%) | $52.13 M(+1.4%) |
| Mar 2011 | - | $12.37 M(-14.2%) | $51.39 M(-0.8%) |
| Dec 2010 | $51.81 M(+24.3%) | $14.41 M(+14.6%) | $51.81 M(+2.6%) |
| Sept 2010 | - | $12.57 M(+4.3%) | $50.50 M(+4.9%) |
| June 2010 | - | $12.05 M(-5.7%) | $48.16 M(+6.9%) |
| Mar 2010 | - | $12.78 M(-2.4%) | $45.05 M(+8.1%) |
| Dec 2009 | $41.68 M(-1.1%) | $13.10 M(+28.1%) | $41.68 M(+3.7%) |
| Sept 2009 | - | $10.23 M(+14.4%) | $40.21 M(+2.0%) |
| June 2009 | - | $8.94 M(-5.0%) | $39.41 M(-4.4%) |
| Mar 2009 | - | $9.41 M(-19.1%) | $41.23 M(-2.2%) |
| Dec 2008 | $42.16 M(+4.7%) | $11.63 M(+23.3%) | $42.16 M(+0.1%) |
| Sept 2008 | - | $9.43 M(-12.3%) | $42.09 M(+0.4%) |
| June 2008 | - | $10.76 M(+4.2%) | $41.94 M(+1.9%) |
| Mar 2008 | - | $10.33 M(-10.7%) | $41.16 M(+2.3%) |
| Dec 2007 | $40.25 M(+5.7%) | $11.56 M(+24.7%) | $40.25 M(+2.5%) |
| Sept 2007 | - | $9.28 M(-7.1%) | $39.28 M(-0.2%) |
| June 2007 | - | $9.98 M(+6.0%) | $39.37 M(+1.9%) |
| Mar 2007 | - | $9.42 M(-11.1%) | $38.63 M(+1.4%) |
| Dec 2006 | $38.09 M(+14.5%) | $10.60 M(+13.2%) | $38.09 M(+4.1%) |
| Sept 2006 | - | $9.36 M(+1.3%) | $36.60 M(+2.4%) |
| June 2006 | - | $9.24 M(+4.1%) | $35.74 M(+3.6%) |
| Mar 2006 | - | $8.88 M(-2.6%) | $34.50 M(+3.7%) |
| Dec 2005 | $33.27 M(+5.9%) | $9.12 M(+7.2%) | $33.27 M(+1.7%) |
| Sept 2005 | - | $8.51 M(+6.4%) | $32.71 M(+2.2%) |
| June 2005 | - | $7.99 M(+4.4%) | $32.01 M(-9.4%) |
| Mar 2005 | - | $7.66 M(-10.5%) | $35.31 M(-7.6%) |
| Dec 2004 | $31.43 M(-27.6%) | $8.55 M(+9.6%) | $38.23 M(-7.6%) |
| Sept 2004 | - | $7.80 M(-30.9%) | $41.40 M(-6.0%) |
| June 2004 | - | $11.30 M(+6.8%) | $44.03 M(-0.3%) |
| Mar 2004 | - | $10.58 M(-9.7%) | $44.15 M(+1.7%) |
| Dec 2003 | $43.41 M(+52.0%) | $11.72 M(+12.3%) | $43.41 M(+6.5%) |
| Sept 2003 | - | $10.44 M(-8.6%) | $40.75 M(+11.6%) |
| June 2003 | - | $11.42 M(+16.1%) | $36.52 M(+13.5%) |
| Mar 2003 | - | $9.84 M(+8.7%) | $32.18 M(+12.7%) |
| Dec 2002 | $28.56 M(+41.2%) | $9.05 M(+45.7%) | $28.56 M(+13.3%) |
| Sept 2002 | - | $6.21 M(-12.1%) | $25.21 M(+3.2%) |
| June 2002 | - | $7.07 M(+13.8%) | $24.42 M(+10.0%) |
| Mar 2002 | - | $6.21 M(+8.8%) | $22.19 M(+9.6%) |
| Dec 2001 | $20.23 M(+30.7%) | $5.71 M(+5.2%) | $20.25 M(+39.3%) |
| Sept 2001 | - | $5.42 M(+12.0%) | $14.54 M(+59.5%) |
| June 2001 | - | $4.84 M(+13.4%) | $9.11 M(+113.4%) |
| Mar 2001 | - | $4.27 M | $4.27 M |
| Dec 2000 | $15.47 M(+15.0%) | - | - |
| Dec 1999 | $13.46 M(+97.8%) | - | - |
| Dec 1998 | $6.80 M | - | - |
FAQ
- What is Harvard Bioscience annual gross profit?
- What is the all time high annual gross profit for Harvard Bioscience?
- What is Harvard Bioscience annual gross profit year-on-year change?
- What is Harvard Bioscience quarterly gross profit?
- What is the all time high quarterly gross profit for Harvard Bioscience?
- What is Harvard Bioscience quarterly gross profit year-on-year change?
- What is Harvard Bioscience TTM gross profit?
- What is the all time high TTM gross profit for Harvard Bioscience?
- What is Harvard Bioscience TTM gross profit year-on-year change?
What is Harvard Bioscience annual gross profit?
The current annual gross profit of HBIO is $66.07 M
What is the all time high annual gross profit for Harvard Bioscience?
Harvard Bioscience all-time high annual gross profit is $67.65 M
What is Harvard Bioscience annual gross profit year-on-year change?
Over the past year, HBIO annual gross profit has changed by +$5.25 M (+8.64%)
What is Harvard Bioscience quarterly gross profit?
The current quarterly gross profit of HBIO is $12.77 M
What is the all time high quarterly gross profit for Harvard Bioscience?
Harvard Bioscience all-time high quarterly gross profit is $19.56 M
What is Harvard Bioscience quarterly gross profit year-on-year change?
Over the past year, HBIO quarterly gross profit has changed by -$1.96 M (-13.32%)
What is Harvard Bioscience TTM gross profit?
The current TTM gross profit of HBIO is $57.08 M
What is the all time high TTM gross profit for Harvard Bioscience?
Harvard Bioscience all-time high TTM gross profit is $68.68 M
What is Harvard Bioscience TTM gross profit year-on-year change?
Over the past year, HBIO TTM gross profit has changed by -$8.50 M (-12.96%)